The routine commissioning of Safinamide (Xadago®) is not accepted in Devon for patients with mid-to-late stage fluctuating Parkinson’s disease.
| Filename: | Safinamide (Xadago®) for mid- to late-stage fluctuating Parkinson’s Disease |
| Filetype: | |
| Filesize: | 92.39 KB |
| Date uploaded: | 26th September 2017 |
| Date updated: | 8th December 2022 |
